Invesaro

Stocks Consumer discretionary SLSN

NASDAQ · Consumer discretionary

Solesence, Inc. (SLSN)

Solesence, Inc. brought in $55.4M of revenue over the twelve months to June 30, 2026, down 14.0% from a year earlier. It posted a net loss of $2.9M. At June 30, 2026 it held $1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 19, 2026.

Free, no password. An email when SLSN files with the SEC.

Price
$0.90
+5.06% on the day · November 9, 2026
52-week range $0.61 to $2.39
Market cap
$63.6M
Revenue (last 12 months)
$55.4M
-14.0% year on year
Net margin
-5.2%
P/E
45.0
on FY2025 diluted EPS

Key facts about Solesence, Inc.

Net worth
Solesence, Inc. has a market value (market cap) of $63.6M at the latest share price, and shareholders' equity of $13.2M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $62.1M (+18.6% year on year), with net income of $1.8M. Over the 12 months to June 30, 2026: revenue $55.4M, net loss $2.9M.
Cash flow
In fiscal 2025 operations used $8.6M of cash.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 19, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
Next earnings report
Solesence, Inc.'s next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

What Solesence, Inc. does

Solesence, Inc. is registered with the SEC under industry code SIC 2844 (Perfumes, Cosmetics & Other Toilet Preparations). Its shares trade on NASDAQ under the ticker SLSN.

Revenue and profit by year

Revenue
FY18: $14.2M $14.2M FY18FY19: $12.5M $12.5M FY19FY20: $17.1M $17.1M FY20FY21: $29.5M $29.5M FY21FY22: $37.3M $37.3M FY22FY23: $37.3M $37.3M FY23FY24: $52.3M $52.3M FY24FY25: $62.1M $62.1M FY25
Net income
FY18: -$2.1M -$2.1M FY18FY19: -$3M -$3M FY19FY20: $989K $989K FY20FY21: $2.3M $2.3M FY21FY22: -$2.6M -$2.6M FY22FY23: -$4.4M -$4.4M FY23FY24: $4.2M $4.2M FY24FY25: $1.8M $1.8M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$62.1M$1.6M$1.8M$0.02n/a
2024$52.3M$5.1M$4.2M$0.07-$2.6M
2023$37.3M-$3.5M-$4.4M-$0.09-$3.1M
2022$37.3M-$2.3M-$2.6M-$0.05-$4.5M
2021$29.5M$2.6M$2.3M$0.05$447K
2020$17.1M$1.5M$989K$0.03-$2.9M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around November 12, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 13, 2025. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where SLSN ranks in Consumer discretionary

Revenue$62.1M
#794 of 1077 in Consumer discretionary · Bottom 26%
Revenue growth+18.6%
#159 of 952 in Consumer discretionary · Top 17%
Net margin2.9%
#469 of 968 in Consumer discretionary · Top 48%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Consumer discretionary

Latest SEC filings

What Solesence, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. October 5, 2026
    Material agreement8-KSolésence extended the maturity dates of three loan agreements with affiliated entities to May 31, 2028.
  2. October 2, 2026
  3. August 21, 2026
  4. August 20, 2026
  5. August 19, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue fell 25% to $15.3M versus the same quarter last year; diluted EPS $0.00 versus $0.04.
  6. August 14, 2026
  7. July 10, 2026
  8. May 12, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue fell 11% to $13M versus the same quarter last year; diluted EPS -$0.01 versus $0.00.
  9. May 12, 2026
  10. April 29, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on December 30, 2025. Insider transactions on SEC

Insider trades

What the people running Solesence, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
December 24, 2025 Whitmore R JanetDirector Bought 1,500 $1.91 $2.9K Form 4
December 24, 2025 Whitmore R JanetDirector Bought 1,000 $1.92 $1.9K Form 4
November 19, 2025 Whitmore R JanetDirector Bought 5,000 $1.95 $9.8K Form 4
November 19, 2025 Whitmore R JanetDirector Bought 5,000 $1.89 $9.5K Form 4
November 18, 2025 Whitmore R JanetDirector Bought 267 $1.83 $488.6 Form 4
November 17, 2025 Whitmore R JanetDirector Bought 5,000 $1.87 $9.4K Form 4
November 14, 2025 Whitmore R JanetDirector Bought 19,789 $1.73 $34.2K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns SLSN

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Whitmore Bradford T13D, may seek influence with 6 related filers 71% 49,826,805 June 2, 2025

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 2,086,698 shares in total, about $1.9M at the last price.

HolderSharesAs of
Whitmore R JanetDirector 2,086,698 December 24, 2025

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about SLSN

What does Solesence, Inc. do?

Solesence, Inc. is a company in the Consumer discretionary sector, listed on NASDAQ as SLSN. Its shares trade on NASDAQ under the ticker SLSN.

What is Solesence, Inc.'s net worth?

Solesence, Inc. has a market value (market cap) of $63.6M at the latest share price, and shareholders' equity of $13.2M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Solesence, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $2.9M on revenue of $55.4M.

How much revenue does Solesence, Inc. make?

Over the twelve months to June 30, 2026 Solesence, Inc. reported revenue of $55.4M. That is 14.0% less than a year earlier.

When did Solesence, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 19, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the material agreement from October 5, 2026.

When is Solesence, Inc.'s next earnings report?

Solesence, Inc.'s next report is expected around November 12, 2026. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare SLSN with

Compare SLSN with any company

Follow SLSN

Get an email when Solesence, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when SLSN files with the SEC.

Where the numbers come from

Financial figures are the values Solesence, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.